Innovative medical devices account for a consumption share of ?

94.2%.The number of innovative medical devices approved since 2022 has reached 39, surpassing the 35 approved in 2021. Approved innovative medical devices China-made products accounted for 94.2% of the total, from the category point of view, mainly concentrated in the field of medical equipment, high-value consumables and in vitro diagnostic reagents. Innovative device track is expected to get marginal improvement by the impact of collective procurement, the National Health Insurance Bureau will be in the centralized band purchasing outside to set aside a certain market for innovative products to open up the market to provide space for innovative devices is expected to be cultivated under the policy, by virtue of the collection outside the market to further realize the value of the product and stimulate the R & D innovation kinetic energy.